[HTML][HTML] Targeting checkpoint receptors and molecules for therapeutic modulation of natural killer cells
N Kim, HS Kim - Frontiers in Immunology, 2018 - frontiersin.org
Among the most promising therapeutic modalities for cancer treatment is the blockade of
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
N Kim, HS Kim - Frontiers in immunology, 2018 - pubmed.ncbi.nlm.nih.gov
Among the most promising therapeutic modalities for cancer treatment is the blockade of
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
[PDF][PDF] Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
N Kim, HS Kim - core.ac.uk
Among the most promising therapeutic modalities for cancer treatment is the blockade of
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
N Kim, HS Kim - Inhibitory Receptors and Pathways of …, 2020 - books.google.com
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
Page 38 REVIEW published: 10 September 2018 doi: 10.3389/fimmu. 2018.02041 Targeting …
Page 38 REVIEW published: 10 September 2018 doi: 10.3389/fimmu. 2018.02041 Targeting …
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
N Kim, HS Kim - Frontiers in Immunology, 2018 - europepmc.org
Among the most promising therapeutic modalities for cancer treatment is the blockade of
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
[HTML][HTML] Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
N Kim, HS Kim - Frontiers in Immunology, 2018 - ncbi.nlm.nih.gov
Among the most promising therapeutic modalities for cancer treatment is the blockade of
immune checkpoint pathways, which are frequently co-opted by tumors as a major …
immune checkpoint pathways, which are frequently co-opted by tumors as a major …